Mr Callahan is a co-founder and President of iCeutica. He has overseen the development of the technology and business strategy and led the transactions with Iroko Pharma and Spree Pharma.  Matt was formerly the General Manager for stock exchange listed ipernica Limited (formerly QPSX Ltd), a technology commercialisation and patent licensing  company, and was responsible for the management of the Company’s operations and ventures in Australia, New Zealand, Germany, the UK and the US.

Mr Callahan was a co-founder of Dimerix Bioscience and Glycan Biosciences and is a director of venture capital firm Stone Ridge Ventures. His prior roles include leading the IP and technology practices for a national law firm.